Avanzanite Bioscience
PrivateLast Round
Series A
Nov 18, 2025
Total Funding Raised
$37.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avanzanite Bioscience is a specialty pharmaceutical company that provides a commercialization and distribution platform for biopharmaceutical partners to launch medicines for rare diseases across Europe.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avanzanite Bioscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Avanzanite Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 18, 2025 |
Key People
Founding team and executive leadership
Avanzanite Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MVM Life Science Partners LLP | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 17% QoQ, from 64 to 75 employees.
- Mar 24, 2026
Operations expanded in France with a new General Manager appointed.
Avanzanite Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avanzanite Bioscience's valuation, stock price, and market status.